RecruitingNot ApplicableNCT03337932
Duration of Doxycycline Treatment in MEM Patients
Duration of Doxycycline Treatment in Patients With Multiple Erythema Migrans (MEM). A Randomized Clinical Trial
Sponsor
University Medical Centre Ljubljana
Enrollment
200 participants
Start Date
May 1, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to compare the efficacy of 7-day versus 14-day doxycycline treatment in patients with multiple erythema migrans.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- multiple erythema migrans
Exclusion Criteria5
- pregnancy or lactation
- immunocompromised
- serious adverse event to doxycycline
- taking antibiotic with antiborrelial activity within 10 days
- extracutaneous manifestations of lyme borreliosis
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGDoxycycline 100 milligram Oral Tablet bid, 7 days
Patients will receive doxycycline for 7 days.
DRUGDoxycycline 100 milligram Oral Tablet bid, 14 days
Patients will receive doxycycline for 14 days.
DRUGControls without a history of lyme disease.
No intervention.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03337932